从耐药性到治疗:与Acinetobacter baumannii的持续斗争
Naji Naseef Pathoor1, Vijetha Valsa2, Pitchaipillai Sankar Ganesh1
1Department of Microbiology, Centre for Infectious Diseases, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University (Deemed to be University), Chennai, Tamil Nadu, India.
巴曼尼菌 (Acinetobacter baumannii) 因其抗生素耐药性而成为日益严重的威胁. 了解其抵抗机制和环境弹性是开发新疗法和感染控制策略的关键.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 抗微生物耐药性 抗微生物耐药性
背景情况:
- 宝曼尼菌 (Acinetobacter baumannii) 是一个重要的医院感染病原体.
- 在A. baumannii中多药耐药性 (MDR) 的快速发展构成了全球卫生挑战.
- 了解耐药机制对于有效的治疗开发至关重要.
研究的目的:
- 在A. baumannii.中全面审查抗生素耐药性机制.
- 探索内在和获得的耐药性,排泄,透性变化,标变化,生物膜形成和水平基因转移.
- 整合环境弹性和治疗策略,以获得全面的理解.
主要方法:
- 对A. baumannii.抗生素耐药性机制的文献综述.
- 分析内在抗性,获得的抗性基因,排泄和外膜透性.
- 研究药物标变化,生物膜形成,水平基因转移和移动遗传元素.
主要成果:
- A. baumannii表现出各种各样的抵抗机制,包括排泄,目标修饰和生物膜形成.
- 环境弹性,特别是耐干燥性和强大的生物膜形成,有助于其持久性.
- 移动遗传元素在耐药性传播中发挥着重要作用.
结论:
- 更深入地了解A. baumannii的抵抗机制和环境因素是必不可少的.
- 洞察力可以指导新型抗菌剂和感染控制策略的开发.
- 解决临床和环境方面的问题对于对抗MDR A. baumannii.是至关重要的.
更多相关视频
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
09:38Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
相关概念视频
Treatment Resistant Cancers
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Drug Therapy
Antianxiety Medications
Ethical Issues
Ethical Concerns in Healthcare:
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
